跳至主要内容
临床试验/NCT03523936
NCT03523936Unknown不适用

Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

Turku University Hospital0 个研究点目标入组 30 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
主要终点
Changes of gut microbiota during antibiotic treatment

研究概览

简要总结

Antibiotics disturb the balance of gut microbiota causing dysbiosis. The purpose of this double-blind placebo controlled intervention study is to investigate whether a new prebiotic product could prevent the side effects of antibiotics.

详细描述

Thirty children (2-6 years of age), who require antibiotic treatment assessed by a doctor, will be enrolled in the study. The children will be randomized to receive either the prebiotic product or placebo during the course of antibiotic treatment.

The children will give a faecal sample in the beginning and at the end of the study. The samples will be used for the analysis of microbiota and differences in the microbiota between the groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
2 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • An infection requiring antibiotic treatment assessed by a doctor

排除标准

  • Coaeliac disease or allergy to cereals, use of other prebiotic/probiotic product during the study

结局指标

主要结局

Changes of gut microbiota during antibiotic treatment

时间窗: One week

Gut microbiota and antibiotics - Prevention of side effects by new prebiotics

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验